GMRTX — GMO U.S. Equity Fund
Data updated: 2026-09-29
GMRTX — GMO U.S. Equity Fund. United States Large Cap Blend / Core Equity · $220.16M AUM · 0.44% expense ratio. Holdings, fees, performance and SEC filings.
GMRTX Fund Overview
GMRTX — GMO U.S. Equity Fund is a US mutual fund managed by Gmo Trust, categorised as United States Large Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Gmo Trust
- Category: United States Large Cap Blend / Core Equity
- Assets under management: $220.16M
- Ticker: GMRTX
- SEC CIK: 0000772129
- SEC series ID: S000004081
- Share class ID: C000011424
GMRTX Investment Objective and Strategy
GMO U.S. Equity Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Gmo Trust.
Investment objective
High total return.
Principal investment strategy
GMO seeks to achieve the Funds investment objective by investing the Funds assets primarily in securities traded in U.S. equity markets. GMO selects the securities the Fund buys and sells based on its evaluation of companies published financial information, securities prices, equity and other markets, the overall global economy, and governmental policies. In selecting securities for the Fund, GMO uses a combination of proprietary quantitative investment methods to identify U.S. equities GMO believes have positive return potential relative to other U.S. equities. Some of these methods evaluate individual companies or groups of companies based on the ratio of their security price to historical financial information and forecasted financial information, such as return on invested capital, profitability, cash flow and earnings, and a comparison of these ratios to current and historical averages.
Other methods focus on patterns of information, such as price movement or volatility of an asset class, security, or market, and macroeconomic factors. In constructing the Funds portfolio, GMO also considers position size, sector and industry exposure, market capitalization, liquidity, and transaction costs. At times, the Fund may have substantial exposure to a single asset class, industry, sector and companies with similar market capitalizations. The Fund may invest in securities of companies of any market capitalization. GMO also may consider ESG (environmental, social and governance) criteria. For example, GMO generally avoids investing the Funds assets in companies engaged in the manufacture, supply, or distribution of cluster munitions, as well as companies primarily involved in the mining and production of thermal coal.
The factors GMO considers and investment methods GMO uses can change over time. As an alternative to investing directly in equities, the Fund may invest in exchange-traded and over-the-counter (OTC) derivatives and exchange-traded funds (ETFs). The Fund also may invest in derivatives and ETFs in an attempt to obtain or adjust elements of its long or short investment exposure. Derivatives used may include futures, options, and swap contracts. In addition, the Fund may lend its portfolio securities. Under normal circumstances, the Fund invests directly and indirectly (e.g., through underlying funds or derivatives) at least 80% of its assets in equities tied economically to the United States (see Name Policies). The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.
GMRTX Holdings
Top 10 holdings of GMO U.S. Equity Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| NVIDIA Corp | 8.22% |
| Apple Inc | 6.83% |
| Alphabet Inc | 4.26% |
| Cisco Systems Inc | 3.36% |
| Microsoft Corp | 3.16% |
| Ford Motor Co | 2.75% |
| Amazon.com Inc | 2.63% |
| QUALCOMM Inc | 2.60% |
| Applied Materials Inc | 2.20% |
| General Motors Co | 2.16% |
GMRTX Portfolio Allocation
Asset-class allocation of GMO U.S. Equity Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 100.3% |
GMRTX Performance
Total returns for GMRTX (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 15.7% |
| 1 year | 43.3% |
| 3 years (annualised) | 25.6% |
| 5 years (annualised) | 15.0% |
GMRTX Risk Information
Risk metrics for GMRTX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 13.2%
GMRTX Costs and Fees
GMRTX costs about $44 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.44%
- Gross expense ratio: 0.51%
- Portfolio turnover: 101%
- Brokerage commissions: 1.14 bps of average net assets (SEC N-CEN)
GMRTX Cashflows
Over the 12 months to 2026-05, GMO U.S. Equity Fund had net outflows of $17.65M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$3.88M |
| 2026-04 | −$236.00K |
| 2026-03 | −$16.06M |
| 2026-02 | $1.40M |
| 2026-01 | $1.07M |
| 2025-12 | $14.32M |
GMRTX Debt Constituents
Largest debt holdings of GMO U.S. Equity Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| United States Treasury | 0.03% |
GMRTX Prospectus and SEC Filings
Official GMO U.S. Equity Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-09-29
- Prospectus (485BPOS) — filed 2026-06-30
- Prospectus supplement (497) — filed 2026-04-29
- Portfolio holdings (N-PORT) — filed 2026-07-29
- Portfolio holdings (N-PORT) — filed 2026-04-29
- Portfolio holdings (N-PORT) — filed 2026-01-29
- Annual census (N-CEN) — filed 2026-05-13
- Annual census (N-CEN) — filed 2025-05-13
Related Funds
Other United States Large Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.